Egetis Therapeutics AB
$1.1238
7
+$0.10+9.37%Friday 13:04
Statistics
Day High
0.8292
Day Low
0.8287
52W High
1.0275
52W Low
0.6353
Volume
17,000
Avg. Volume
1,137
Mkt Cap
477.73M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
Nov 6Expected
Q1 2026
Q2 2026
Next
-0.03
-0.02
-0.02
-0.02
Expected EPS
-0.0195623965
Actual EPS
N/A
Financials
-550.3%Profit Margin
Unprofitable6.58MRevenue
-36.2MNet Income
People Also Follow
This list is based on the watchlists of people on Stock Events who follow PDPHF. It's not an investment recommendation.
Svenska Handelsbanken AB (publ)
2
SHB-A.ST
Volvo AB
2
VOLV-B.ST
Skandinaviska Enskilda Banken AB.
2
SEB-A.ST
Lundin Mining
2
LUMI.ST
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Egetis Therapeutics AB (publ) is a pharmaceutical enterprise committed to progressing drug development, primarily focusing on late-stage projects. The company's core mission involves addressing significant unmet medical needs within the orphan drug sector, concentrating on severe and rare or niche diseases. Its current therapeutic pipeline includes two key drugs undergoing Phase IIb/III clinical trials: Aladote, which is designed to mitigate the risk of acute liver damage associated with acetaminophen/paracetamol poisoning, and Emcitate, intended for the management of MCT8 deficiency, a rare congenital disorder impacting thyroid hormone signaling. Established in 2006, Egetis Therapeutics AB (publ) is headquartered in Stockholm, Sweden, and was previously known as PledPharma AB (publ) until its name change in December 2020.
Show More
CEO
Nicklas Westerholm
Employees
56
Country
Sweden
ISIN
SE0003815604
WKN
000A1JH3B
Listings
0 Comments
Share your thoughts
FAQs
What is Egetis Therapeutics AB stock price today?▼
The current price of PDPHF is $1.12 USD — it has increased by +9.37% in the past 24 hours. Watch Egetis Therapeutics AB stock price performance more closely on the chart.
What is Egetis Therapeutics AB stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Egetis Therapeutics AB stocks are traded under the ticker PDPHF.
What is Egetis Therapeutics AB market cap?▼
Today Egetis Therapeutics AB has the market capitalization of 477.73M
When is the next Egetis Therapeutics AB earnings date?▼
Egetis Therapeutics AB is going to release the next earnings report on February 25, 2027.
What is Egetis Therapeutics AB revenue for the last year?▼
Egetis Therapeutics AB revenue for the last year amounts to 6.58M USD.
What is Egetis Therapeutics AB net income for the last year?▼
PDPHF net income for the last year is -36.2M USD.
How many employees does Egetis Therapeutics AB have?▼
As of November 8, 2026, the company has 56 employees.
In which sector is Egetis Therapeutics AB located?▼
Egetis Therapeutics AB operates in the Health & Wellness sector.
When did Egetis Therapeutics AB complete a stock split?▼
Egetis Therapeutics AB has not had any recent stock splits.
Where is Egetis Therapeutics AB headquartered?▼
Egetis Therapeutics AB is headquartered in Stockholm, Sweden.